Back

Identification of potential colorectal-cancer-protective bioactive natural compounds in the human gut microbiome

Leuzzi, D.; Rampelli, S.; Savojardo, C.; Scicchitano, D.; D'Amico, F.; Frisan, T.; Martelli, P. L.; Candela, M.; Turroni, S.

2026-02-18 microbiology
10.64898/2026.02.17.706414 bioRxiv
Show abstract

Increasing evidence links the gut microbiome to the development and progression of colorectal cancer (CRC). Despite the remarkable diversity of microbial biosynthetic gene clusters (BGCs), no CRC-protective bioactive natural compounds originating from gut microbiome BGCs have yet been detected. Here, we investigated BGCs within de novo gut metagenome-assembled species reconstructed from 559 individuals, including healthy controls, adenoma and CRC patients. Comparative analysis revealed distinct BGC patterns across groups, with four BGCs being significantly enriched in healthy individuals. One of these was predicted to be involved in the biosynthesis of a metabolite closely related to the anticancer compound curacin-A. Notably, this BGC was also overrepresented in healthy centenarians, suggesting a role in achieving long-term cancer-free health. Our findings highlight the importance of exploring gut microbiome BGCs as a source of novel bioactive molecules for cancer prevention and treatment, as well as for other health purposes.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.